YAP1 Expression in HR+HER2− Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation

YAP1 Expression in HR+HER2− Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation

Background: YAP1, an oncogene in numerous cancers, is a downstream transcription factor of the Hippo pathway. This study focuses on its relationship with the Oncotype Dx (ODX) test risk score (RS) in patients with hormone-receptor-positive, HER2-negative (HR+HER2−) breast cancer. Methods: We retrosp...

Full description

Bibliographic Details
Main Authors: Inho Park, Yangkyu Lee, Jee Hung Kim, Soong June Bae, Sung Gwe Ahn, Joon Jeong, Yoon Jin Cha
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
breast neoplasms
Yes-associated protein 1
prognosis
receptors
estrogen
pathology
Online Access:https://www.mdpi.com/2072-6694/15/20/5034

Internet

https://www.mdpi.com/2072-6694/15/20/5034

Similar Items